| Year |
Citation |
Score |
| 2016 |
Wedel J, Nakayama H, Kochupurakkal NM, Koch J, Klagsbrun M, Bielenberg DR, Briscoe DM. The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/tolerance. Current Opinion in Organ Transplantation. PMID 27898465 DOI: 10.1097/Mot.0000000000000373 |
0.361 |
|
| 2016 |
Mucka P, Levonyak N, Geretti E, Zwaans BM, Li X, Adini I, Klagsbrun M, Adam RM, Bielenberg DR. Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency. The American Journal of Pathology. PMID 27751443 DOI: 10.1016/J.Ajpath.2016.07.022 |
0.385 |
|
| 2016 |
Boneschansker L, Nakayama H, Eisenga M, Wedel J, Klagsbrun M, Irimia D, Briscoe DM. Netrin-1 Augments Chemokinesis in CD4+ T Cells In Vitro and Elicits a Proinflammatory Response In Vivo. Journal of Immunology (Baltimore, Md. : 1950). PMID 27430720 DOI: 10.4049/Jimmunol.1502432 |
0.315 |
|
| 2016 |
Shim JW, Sandlund J, Hameed MQ, Blazer-Yost B, Zhou FC, Klagsbrun M, Madsen JR. Excess HB-EGF, which promotes VEGF signaling, leads to hydrocephalus. Scientific Reports. 6: 26794. PMID 27243144 DOI: 10.1038/Srep26794 |
0.491 |
|
| 2015 |
Yoshida A, Shimizu A, Asano H, Kadonosono T, Kondoh SK, Geretti E, Mammoto A, Klagsbrun M, Seo MK. VEGF-A/NRP1 stimulates GIPC1 and Syx complex formation to promote RhoA activation and proliferation in skin cancer cells. Biology Open. 4: 1063-76. PMID 26209534 DOI: 10.1242/Bio.010918 |
0.467 |
|
| 2015 |
Nakayama H, Bruneau S, Kochupurakkal N, Coma S, Briscoe DM, Klagsbrun M. Regulation of mTOR Signaling by Semaphorin 3F-Neuropilin 2 Interactions In Vitro and In Vivo. Scientific Reports. 5: 11789. PMID 26156437 DOI: 10.1038/Srep11789 |
0.465 |
|
| 2015 |
Nakayama H, Huang L, Kelly RP, Oudenaarden CR, Dagher A, Hofmann NA, Moses MA, Bischoff J, Klagsbrun M. Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins. Biochemical and Biophysical Research Communications. PMID 26086095 DOI: 10.1016/J.Bbrc.2015.06.087 |
0.436 |
|
| 2015 |
Hofmann NA, Yang J, Trauger SA, Nakayama H, Huang L, Strunk D, Moses MA, Klagsbrun M, Bischoff J, Graier WF. The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis. British Journal of Pharmacology. PMID 25989290 DOI: 10.1111/Bph.13196 |
0.406 |
|
| 2015 |
Adapala RK, Thoppil RJ, Ghosh K, Cappelli HC, Dudley AC, Paruchuri S, Keshamouni V, Klagsbrun M, Meszaros JG, Chilian WM, Ingber DE, Thodeti CK. Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy. Oncogene. PMID 25867067 DOI: 10.1038/Onc.2015.83 |
0.411 |
|
| 2015 |
Boscolo E, Coma S, Luks VL, Greene AK, Klagsbrun M, Warman ML, Bischoff J. AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation. Angiogenesis. 18: 151-62. PMID 25424831 DOI: 10.1007/S10456-014-9453-2 |
0.35 |
|
| 2015 |
Huang L, Nakayama H, Klagsbrun M, Mulliken JB, Bischoff J. Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells. Stem Cells (Dayton, Ohio). 33: 133-45. PMID 25187207 DOI: 10.1002/Stem.1841 |
0.44 |
|
| 2014 |
Panigrahy D, Adini I, Mamluk R, Levonyak N, Bruns CJ, D'Amore PA, Klagsbrun M, Bielenberg DR. Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration. Pathology. 46: 416-23. PMID 24977735 DOI: 10.1097/Pat.0000000000000121 |
0.412 |
|
| 2014 |
Akino T, Han X, Nakayama H, McNeish B, Zurakowski D, Mammoto A, Klagsbrun M, Smith E. Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma. Cancer Research. 74: 3716-26. PMID 24812271 DOI: 10.1158/0008-5472.Can-13-3116 |
0.393 |
|
| 2014 |
Procaccia V, Nakayama H, Shimizu A, Klagsbrun M. Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motility. Biochemical and Biophysical Research Communications. 448: 134-8. PMID 24759231 DOI: 10.1016/J.Bbrc.2014.04.063 |
0.339 |
|
| 2014 |
Snurdel M, Batista A, Kirkpatrick N, Almodovar C, Riedemann L, Peterson T, Ferrara N, Klagsbrun M, Duda DG, Fukumura D, Xu L, Carmeliet P, Jain R. Abstract IA17: Targeting placental growth factor/ neuropilin-1 pathway inhibits growth and spread of medulloblastoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-Ia17 |
0.455 |
|
| 2013 |
Gerald D, Adini I, Shechter S, Perruzzi C, Varnau J, Hopkins B, Kazerounian S, Kurschat P, Blachon S, Khedkar S, Bagchi M, Sherris D, Prendergast GC, Klagsbrun M, Stuhlmann H, et al. RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription. Nature Communications. 4: 2824. PMID 24280686 DOI: 10.1038/Ncomms3824 |
0.407 |
|
| 2013 |
Coma S, Allard-Ratick M, Akino T, van Meeteren LA, Mammoto A, Klagsbrun M. GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2. Angiogenesis. 16: 939-52. PMID 23892628 DOI: 10.1007/S10456-013-9370-9 |
0.448 |
|
| 2013 |
Shim JW, Sandlund J, Han CH, Hameed MQ, Connors S, Klagsbrun M, Madsen JR, Irwin N. VEGF, which is elevated in the CSF of patients with hydrocephalus, causes ventriculomegaly and ependymal changes in rats. Experimental Neurology. 247: 703-9. PMID 23518418 DOI: 10.1016/J.Expneurol.2013.03.011 |
0.394 |
|
| 2013 |
Snuderl M, Batista A, Kirkpatrick ND, Ruiz de Almodovar C, Riedemann L, Walsh EC, Anolik R, Huang Y, Martin JD, Kamoun W, Knevels E, Schmidt T, Farrar CT, Vakoc BJ, Mohan N, ... ... Klagsbrun M, et al. Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma. Cell. 152: 1065-76. PMID 23452854 DOI: 10.1016/J.Cell.2013.01.036 |
0.455 |
|
| 2013 |
Shimizu A, Nakayama H, Wang P, König C, Akino T, Sandlund J, Coma S, Italiano JE, Mammoto A, Bielenberg DR, Klagsbrun M. Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein. The Journal of Biological Chemistry. 288: 2210-22. PMID 23195957 DOI: 10.1074/Jbc.M112.397398 |
0.445 |
|
| 2012 |
Di Vizio D, Morello M, Dudley AC, Schow PW, Adam RM, Morley S, Mulholland D, Rotinen M, Hager MH, Insabato L, Moses MA, Demichelis F, Lisanti MP, Wu H, Klagsbrun M, et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. The American Journal of Pathology. 181: 1573-84. PMID 23022210 DOI: 10.1016/J.Ajpath.2012.07.030 |
0.357 |
|
| 2012 |
Bielenberg DR, Seth A, Shimizu A, Pelton K, Cristofaro V, Ramachandran A, Zwaans BM, Chen C, Krishnan R, Seth M, Huang L, Takashima S, Klagsbrun M, Sullivan MP, Adam RM. Increased smooth muscle contractility in mice deficient for neuropilin 2. The American Journal of Pathology. 181: 548-59. PMID 22688055 DOI: 10.1016/J.Ajpath.2012.04.013 |
0.335 |
|
| 2012 |
Wagner M, Bjerkvig R, Wiig H, Melero-Martin JM, Lin RZ, Klagsbrun M, Dudley AC. Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis. Angiogenesis. 15: 481-95. PMID 22614697 DOI: 10.1007/S10456-012-9276-Y |
0.363 |
|
| 2012 |
Wong HK, Shimizu A, Kirkpatrick ND, Garkavtsev I, Chan AW, di Tomaso E, Klagsbrun M, Jain RK. Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism. Neoplasia (New York, N.Y.). 14: 84-94. PMID 22431917 DOI: 10.1593/Neo.111600 |
0.361 |
|
| 2011 |
Cao Y, Arbiser J, D'Amato RJ, D'Amore PA, Ingber DE, Kerbel R, Klagsbrun M, Lim S, Moses MA, Zetter B, Dvorak H, Langer R. Forty-year journey of angiogenesis translational research. Science Translational Medicine. 3: 114rv3. PMID 22190240 DOI: 10.1126/Scitranslmed.3003149 |
0.315 |
|
| 2011 |
Grandclement C, Pallandre JR, Valmary Degano S, Viel E, Bouard A, Balland J, Rémy-Martin JP, Simon B, Rouleau A, Boireau W, Klagsbrun M, Ferrand C, Borg C. Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells. Plos One. 6: e20444. PMID 21747928 DOI: 10.1371/Journal.Pone.0020444 |
0.382 |
|
| 2011 |
Coma S, Shimizu A, Klagsbrun M. Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2. Cell Adhesion & Migration. 5: 266-75. PMID 21610314 DOI: 10.4161/Cam.5.3.16294 |
0.48 |
|
| 2011 |
Joyal JS, Sitaras N, Binet F, Rivera JC, Stahl A, Zaniolo K, Shao Z, Polosa A, Zhu T, Hamel D, Djavari M, Kunik D, Honoré JC, Picard E, Zabeida A, ... ... Klagsbrun M, et al. Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A. Blood. 117: 6024-35. PMID 21355092 DOI: 10.1182/Blood-2010-10-311589 |
0.303 |
|
| 2010 |
Klagsbrun M, Shimizu A. Semaphorin 3E, an exception to the rule. The Journal of Clinical Investigation. 120: 2658-60. PMID 20664165 DOI: 10.1172/Jci44110 |
0.374 |
|
| 2010 |
Geretti E, van Meeteren LA, Shimizu A, Dudley AC, Claesson-Welsh L, Klagsbrun M. A mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progression. Molecular Cancer Research : McR. 8: 1063-73. PMID 20651020 DOI: 10.1158/1541-7786.Mcr-10-0157 |
0.474 |
|
| 2010 |
Dudley AC, Udagawa T, Melero-Martin JM, Shih SC, Curatolo A, Moses MA, Klagsbrun M. Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors. Blood. 116: 3367-71. PMID 20453162 DOI: 10.1182/Blood-2010-02-271122 |
0.393 |
|
| 2010 |
Coma S, Amin DN, Shimizu A, Lasorella A, Iavarone A, Klagsbrun M. Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F. Cancer Research. 70: 3823-32. PMID 20388805 DOI: 10.1158/0008-5472.Can-09-3048 |
0.373 |
|
| 2010 |
Matsuda K, Ohga N, Hida Y, Muraki C, Tsuchiya K, Kurosu T, Akino T, Shih SC, Totsuka Y, Klagsbrun M, Shindoh M, Hida K. Isolated tumor endothelial cells maintain specific character during long-term culture. Biochemical and Biophysical Research Communications. 394: 947-54. PMID 20302845 DOI: 10.1016/J.Bbrc.2010.03.089 |
0.404 |
|
| 2010 |
Melero-Martin JM, De Obaldia ME, Allen P, Dudley AC, Klagsbrun M, Bischoff J. Host myeloid cells are necessary for creating bioengineered human vascular networks in vivo. Tissue Engineering. Part A. 16: 2457-66. PMID 20218762 DOI: 10.1089/Ten.Tea.2010.0024 |
0.408 |
|
| 2010 |
Hida K, Akino T, Hida Y, Tsuchiya K, Freedman D, Muraki C, Ohga N, Matsuda K, Akiyama K, Kurosu T, Kondo M, Maishi N, Harabayashi T, Shinohara N, Nonomura K, ... Klagsbrun M, et al. Abstract 1308: Cytogenetic abnormalities of tumor endothelial cells in human malignant tumors Cancer Research. 70: 1308-1308. DOI: 10.1158/1538-7445.Am10-1308 |
0.357 |
|
| 2009 |
Akino T, Hida K, Hida Y, Tsuchiya K, Freedman D, Muraki C, Ohga N, Matsuda K, Akiyama K, Harabayashi T, Shinohara N, Nonomura K, Klagsbrun M, Shindoh M. Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors. The American Journal of Pathology. 175: 2657-67. PMID 19875502 DOI: 10.2353/Ajpath.2009.090202 |
0.347 |
|
| 2009 |
Dudley AC, Klagsbrun M. Tumor endothelial cells join the resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4787-9. PMID 19638456 DOI: 10.1158/1078-0432.Ccr-09-0902 |
0.351 |
|
| 2009 |
Dudley AC, Klagsbrun M. Tumor endothelial cells have features of adult stem cells. Cell Cycle (Georgetown, Tex.). 8: 236-8. PMID 19158490 DOI: 10.4161/Cc.8.2.7413 |
0.386 |
|
| 2009 |
Shim JW, Dudley A, Klagsbrun M, Smith S, Madsen JR. Effect of rhHB-EGF on the expression of hydrocephalus-related genes in vitro Cerebrospinal Fluid Research. 6. DOI: 10.1186/1743-8454-6-S1-S5 |
0.465 |
|
| 2008 |
Dudley AC, Khan ZA, Shih SC, Kang SY, Zwaans BM, Bischoff J, Klagsbrun M. Calcification of multipotent prostate tumor endothelium. Cancer Cell. 14: 201-11. PMID 18772110 DOI: 10.1016/J.Ccr.2008.06.017 |
0.393 |
|
| 2008 |
Bielenberg DR, Shimizu A, Klagsbrun M. Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells. Methods in Enzymology. 443: 299-314. PMID 18772022 DOI: 10.1016/S0076-6879(08)02015-6 |
0.39 |
|
| 2008 |
Ghosh K, Thodeti CK, Dudley AC, Mammoto A, Klagsbrun M, Ingber DE. Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. Proceedings of the National Academy of Sciences of the United States of America. 105: 11305-10. PMID 18685096 DOI: 10.1073/Pnas.0800835105 |
0.415 |
|
| 2008 |
Kawamura H, Li X, Goishi K, van Meeteren LA, Jakobsson L, Cébe-Suarez S, Shimizu A, Edholm D, Ballmer-Hofer K, Kjellén L, Klagsbrun M, Claesson-Welsh L. Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood. 112: 3638-49. PMID 18664627 DOI: 10.1182/Blood-2007-12-125856 |
0.447 |
|
| 2008 |
Shimizu A, Mammoto A, Italiano JE, Pravda E, Dudley AC, Ingber DE, Klagsbrun M. ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells. The Journal of Biological Chemistry. 283: 27230-8. PMID 18660502 DOI: 10.1074/Jbc.M804520200 |
0.389 |
|
| 2008 |
Amin DN, Bielenberg DR, Lifshits E, Heymach JV, Klagsbrun M. Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells. Microvascular Research. 76: 15-22. PMID 18440031 DOI: 10.1016/J.Mvr.2008.01.002 |
0.424 |
|
| 2008 |
Geretti E, Shimizu A, Klagsbrun M. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis. 11: 31-9. PMID 18283547 DOI: 10.1007/S10456-008-9097-1 |
0.395 |
|
| 2008 |
Akino T, Hida K, Tsuchiya K, Hida Y, Klagsbrun M, Matsuda K, Ohga N, Abe T, Sazawa A, Harabayashi T, Shinohara N, Shindoh M, Nonomura K. Chromosomal Abnormalities Of Tumor Endothelial Cells In Human Renal Cell Carcinoma The Journal of Urology. 179: 133-133. DOI: 10.1016/S0022-5347(08)60382-1 |
0.349 |
|
| 2008 |
Klagsbrun M, Moses MA. Judah Folkman, M.D. February 24, 1933–January 14, 2008 Cancer Cell. 13: 81-82. DOI: 10.1016/J.Ccr.2008.01.020 |
0.371 |
|
| 2007 |
Geretti E, Klagsbrun M. Neuropilins: novel targets for anti-angiogenesis therapies. Cell Adhesion & Migration. 1: 56-61. PMID 19329879 DOI: 10.4161/Cam.1.2.4490 |
0.432 |
|
| 2007 |
Bielenberg DR, Klagsbrun M. Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Reviews. 26: 421-31. PMID 17768598 DOI: 10.1007/S10555-007-9097-4 |
0.463 |
|
| 2007 |
Bahary N, Goishi K, Stuckenholz C, Weber G, Leblanc J, Schafer CA, Berman SS, Klagsbrun M, Zon LI. Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish. Blood. 110: 3627-36. PMID 17698971 DOI: 10.1182/Blood-2006-04-016378 |
0.444 |
|
| 2007 |
Geretti E, Shimizu A, Kurschat P, Klagsbrun M. Site-directed mutagenesis in the B-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F. The Journal of Biological Chemistry. 282: 25698-707. PMID 17595163 DOI: 10.1074/Jbc.M702942200 |
0.396 |
|
| 2006 |
Amin DN, Hida K, Bielenberg DR, Klagsbrun M. Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Research. 66: 2173-80. PMID 16489018 DOI: 10.1158/0008-5472.Can-05-3387 |
0.488 |
|
| 2006 |
Bielenberg DR, Pettaway CA, Takashima S, Klagsbrun M. Neuropilins in neoplasms: expression, regulation, and function. Experimental Cell Research. 312: 584-93. PMID 16445911 DOI: 10.1016/J.Yexcr.2005.11.024 |
0.483 |
|
| 2006 |
Kurschat P, Bielenberg D, Rossignol-Tallandier M, Stahl A, Klagsbrun M. Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration. The Journal of Biological Chemistry. 281: 2721-9. PMID 16330548 DOI: 10.1074/Jbc.M507860200 |
0.502 |
|
| 2005 |
Mamluk R, Klagsbrun M, Detmar M, Bielenberg DR. Soluble neuropilin targeted to the skin inhibits vascular permeability. Angiogenesis. 8: 217-27. PMID 16328161 DOI: 10.1007/S10456-005-9009-6 |
0.454 |
|
| 2005 |
Stahl A, Wu X, Wenger A, Klagsbrun M, Kurschat P. Endothelial progenitor cell sprouting in spheroid cultures is resistant to inhibition by osteoblasts: a model for bone replacement grafts. Febs Letters. 579: 5338-42. PMID 16194535 DOI: 10.1016/J.Febslet.2005.09.005 |
0.383 |
|
| 2005 |
Klagsbrun M, Eichmann A. A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine & Growth Factor Reviews. 16: 535-48. PMID 15979925 DOI: 10.1016/J.Cytogfr.2005.05.002 |
0.367 |
|
| 2005 |
Wey JS, Gray MJ, Fan F, Belcheva A, McCarty MF, Stoeltzing O, Somcio R, Liu W, Evans DB, Klagsbrun M, Gallick GE, Ellis LM. Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. British Journal of Cancer. 93: 233-41. PMID 15956974 DOI: 10.1038/Sj.Bjc.6602663 |
0.372 |
|
| 2005 |
Hida K, Klagsbrun M. A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities. Cancer Research. 65: 2507-10. PMID 15805239 DOI: 10.1158/0008-5472.Can-05-0002 |
0.402 |
|
| 2004 |
Nishi E, Klagsbrun M. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways. Growth Factors (Chur, Switzerland). 22: 253-60. PMID 15621728 DOI: 10.1080/08977190400008448 |
0.442 |
|
| 2004 |
Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC, Klagsbrun M. Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Research. 64: 8249-55. PMID 15548691 DOI: 10.1158/0008-5472.Can-04-1567 |
0.409 |
|
| 2004 |
Goishi K, Klagsbrun M. Vascular endothelial growth factor and its receptors in embryonic zebrafish blood vessel development. Current Topics in Developmental Biology. 62: 127-52. PMID 15522741 DOI: 10.1016/S0070-2153(04)62005-9 |
0.44 |
|
| 2004 |
Bielenberg DR, Hida Y, Shimizu A, Kaipainen A, Kreuter M, Kim CC, Klagsbrun M. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. The Journal of Clinical Investigation. 114: 1260-71. PMID 15520858 DOI: 10.1172/Jci21378 |
0.426 |
|
| 2004 |
Kutcher ME, Klagsbrun M, Mamluk R. VEGF is required for the maintenance of dorsal root ganglia blood vessels but not neurons during development. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1952-4. PMID 15479766 DOI: 10.1096/Fj.04-2320Fje |
0.425 |
|
| 2004 |
Bovenkamp DE, Goishi K, Bahary N, Davidson AJ, Zhou Y, Becker T, Becker CG, Zon LI, Klagsbrun M. Expression and mapping of duplicate neuropilin-1 and neuropilin-2 genes in developing zebrafish. Gene Expression Patterns : Gep. 4: 361-70. PMID 15183302 DOI: 10.1016/J.Modgep.2004.01.014 |
0.35 |
|
| 2004 |
Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, Reinmuth N, Bielenberg D, Bucana CD, Klagsbrun M, Ellis LM. Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. The American Journal of Pathology. 164: 2139-51. PMID 15161648 DOI: 10.1016/S0002-9440(10)63772-8 |
0.493 |
|
| 2003 |
Goishi K, Lee P, Davidson AJ, Nishi E, Zon LI, Klagsbrun M. Inhibition of zebrafish epidermal growth factor receptor activity results in cardiovascular defects. Mechanisms of Development. 120: 811-22. PMID 12915231 DOI: 10.1016/S0925-4773(03)00068-6 |
0.351 |
|
| 2003 |
Iwamoto R, Yamazaki S, Asakura M, Takashima S, Hasuwa H, Miyado K, Adachi S, Kitakaze M, Hashimoto K, Raab G, Nanba D, Higashiyama S, Hori M, Klagsbrun M, Mekada E. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proceedings of the National Academy of Sciences of the United States of America. 100: 3221-6. PMID 12621152 DOI: 10.1073/Pnas.0537588100 |
0.346 |
|
| 2003 |
Rossignol M, Pouysségur J, Klagsbrun M. Characterization of the neuropilin-1 promoter; gene expression is mediated by the transcription factor Sp1. Journal of Cellular Biochemistry. 88: 744-57. PMID 12577308 DOI: 10.1002/Jcb.10384 |
0.373 |
|
| 2002 |
Klagsbrun M, Takashima S, Mamluk R. The role of neuropilin in vascular and tumor biology. Advances in Experimental Medicine and Biology. 515: 33-48. PMID 12613541 DOI: 10.1007/978-1-4615-0119-0_3 |
0.469 |
|
| 2002 |
Lee P, Goishi K, Davidson AJ, Mannix R, Zon L, Klagsbrun M. Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proceedings of the National Academy of Sciences of the United States of America. 99: 10470-5. PMID 12142468 DOI: 10.1073/Pnas.162366299 |
0.453 |
|
| 2002 |
Jin K, Mao XO, Sun Y, Xie L, Jin L, Nishi E, Klagsbrun M, Greenberg DA. Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 5365-73. PMID 12097488 DOI: 10.1523/Jneurosci.22-13-05365.2002 |
0.42 |
|
| 2002 |
Hospital V, Nishi E, Klagsbrun M, Cohen P, Seidah NG, Prat A. The metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF). The Biochemical Journal. 367: 229-38. PMID 12095415 DOI: 10.1042/Bj20020822 |
0.438 |
|
| 2002 |
Mamluk R, Gechtman Z, Kutcher ME, Gasiunas N, Gallagher J, Klagsbrun M. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain. The Journal of Biological Chemistry. 277: 24818-25. PMID 11986311 DOI: 10.1074/Jbc.M200730200 |
0.435 |
|
| 2002 |
Soker S, Miao HQ, Nomi M, Takashima S, Klagsbrun M. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. Journal of Cellular Biochemistry. 85: 357-68. PMID 11948691 DOI: 10.1002/Jcb.10140 |
0.465 |
|
| 2002 |
Takashima S, Kitakaze M, Asakura M, Asanuma H, Sanada S, Tashiro F, Niwa H, Miyazaki Ji J, Hirota S, Kitamura Y, Kitsukawa T, Fujisawa H, Klagsbrun M, Hori M. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proceedings of the National Academy of Sciences of the United States of America. 99: 3657-62. PMID 11891274 DOI: 10.1073/Pnas.022017899 |
0.303 |
|
| 2001 |
Soker S, Kaefer M, Johnson M, Klagsbrun M, Atala A, Freeman MR. Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype. American Journal of Pathology. 159: 651-659. PMID 11485923 DOI: 10.1016/S0002-9440(10)61736-1 |
0.485 |
|
| 2001 |
Nishi E, Prat A, Hospital V, Elenius K, Klagsbrun M. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration Embo Journal. 20: 3342-3350. PMID 11432822 DOI: 10.1093/Emboj/20.13.3342 |
0.469 |
|
| 2001 |
Harper J, Gerstenfeld LC, Klagsbrun M. Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes. Journal of Cellular Biochemistry. 81: 82-92. PMID 11180399 DOI: 10.1002/1097-4644(20010401)81:1<82::Aid-Jcb1025>3.0.Co;2-P |
0.647 |
|
| 2000 |
Miao H, Klagsbrun M. Neuropilin is a mediator of angiogenesis. Cancer and Metastasis Reviews. 19: 29-37. PMID 11191060 DOI: 10.1023/A:1026579711033 |
0.431 |
|
| 2000 |
Rossignol M, Gagnon ML, Klagsbrun M. Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics. 70: 211-222. PMID 11112349 DOI: 10.1006/Geno.2000.6381 |
0.361 |
|
| 2000 |
Miao H, Lee P, Lin H, Soker S, Klagsbrun M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression The Faseb Journal. 14: 2532-2539. PMID 11099472 DOI: 10.1096/Fj.00-0250Com |
0.411 |
|
| 2000 |
Kainulainen V, Sundvall M, Määttä JA, Santiestevan E, Klagsbrun M, Elenius K. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis. Journal of Biological Chemistry. 275: 8641-8649. PMID 10722704 DOI: 10.1074/Jbc.275.12.8641 |
0.396 |
|
| 2000 |
Halder JB, Zhao X, Soker S, Paria BC, Klagsbrun M, Das SK, Dey SK. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation. Genesis (New York, N.Y. : 2000). 26: 213-24. PMID 10705382 DOI: 10.1002/(Sici)1526-968X(200003)26:3<213::Aid-Gene7>3.0.Co;2-M |
0.456 |
|
| 2000 |
Gagnon ML, Bielenberg DR, Gechtman Z, Miao H, Takashima S, Soker S, Klagsbrun M. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity Proceedings of the National Academy of Sciences of the United States of America. 97: 2573-2578. PMID 10688880 DOI: 10.1073/Pnas.040337597 |
0.519 |
|
| 1999 |
Park JM, Adam RM, Peters CA, Guthrie PD, Sun Z, Klagsbrun M, Freeman MR. AP-1 mediates stretch-induced expression of HB-EGF in bladder smooth muscle cells. American Journal of Physiology. Cell Physiology. 277: C294-C301. PMID 29590843 DOI: 10.1152/Ajpcell.1999.277.2.C294 |
0.406 |
|
| 1999 |
Gechtman Z, Alonso JL, Raab G, Ingber DE, Klagsbrun M. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. The Journal of Biological Chemistry. 274: 28828-35. PMID 10497257 DOI: 10.1074/Jbc.274.40.28828 |
0.373 |
|
| 1999 |
Arbiser JL, Raab G, Rohan RM, Paul S, Hirschi K, Flynn E, Price ER, Fisher DE, Cohen C, Klagsbrun M. Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity. American Journal of Pathology. 155: 723-729. PMID 10487830 DOI: 10.1016/S0002-9440(10)65171-1 |
0.432 |
|
| 1999 |
Makinen T, Olofsson B, Karpanen T, Hellman U, Soker S, Klagsbrun M, Eriksson U, Alitalo K. Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. The Journal of Biological Chemistry. 274: 21217-22. PMID 10409677 DOI: 10.1074/Jbc.274.30.21217 |
0.421 |
|
| 1999 |
Miao HQ, Soker S, Feiner L, Alonso JL, Raper JA, Klagsbrun M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. The Journal of Cell Biology. 146: 233-42. PMID 10402473 DOI: 10.1083/Jcb.146.1.233 |
0.482 |
|
| 1999 |
Harper J, Klagsbrun M. Cartilage to bone--angiogenesis leads the way. Nature Medicine. 5: 617-618. PMID 10371495 DOI: 10.1038/9460 |
0.645 |
|
| 1999 |
Elenius K, Choi CJ, Paul S, Santiestevan E, Nishi E, Klagsbrun M. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase. Oncogene. 18: 2607-15. PMID 10353604 DOI: 10.1038/Sj.Onc.1202612 |
0.339 |
|
| 1999 |
Gagnon ML, Moy GK, Klagsbrun M. Characterization of the promoter for the human antisense fibroblast growth factor-2 gene; Regulation by Ets in Jurkat T cells Journal of Cellular Biochemistry. 72: 492-506. PMID 10022609 DOI: 10.1002/(Sici)1097-4644(19990315)72:4<492::Aid-Jcb5>3.0.Co;2-H |
0.4 |
|
| 1999 |
Nakano N, Higashiyama S, Takashima S, Tsuruoka N, Klagsbrun M, Taniguchi N. Purification and characterization of a novel vascular endothelial cell growth inhibitor secreted by macrophage-like U-937 cells. Journal of Biochemistry. 125: 368-374. PMID 9990136 DOI: 10.1093/Oxfordjournals.Jbchem.A022296 |
0.529 |
|
| 1999 |
Park JM, Adam RM, Guthrie PD, Sun ZJ, Klagsbrun M, Peters CA, Freeman MR. Activator Protein-1 Mediates Stretch-Activated Heparin-Binding Egf-Like Growth Factor Expression In Bladder Smooth Muscle Cells The Journal of Urology. 39. DOI: 10.1097/00005392-199904010-00160 |
0.423 |
|
| 1998 |
Giraudo E, Primo L, Audero E, Gerber HP, Koolwijk P, Soker S, Klagsbrun M, Ferrara N, Bussolino F. Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial Cells Journal of Biological Chemistry. 273: 22128-22135. PMID 9705358 DOI: 10.1074/Jbc.273.34.22128 |
0.434 |
|
| 1998 |
Yancopoulos GD, Klagsbrun M, Folkman J. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell. 93: 661-4. PMID 9630209 DOI: 10.1016/S0092-8674(00)81426-9 |
0.465 |
|
| 1998 |
Dethlefsen SM, Raab G, Moses MA, Adam RM, Klagsbrun M, Freeman MR. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C. Journal of Cellular Biochemistry. 69: 143-53. PMID 9548562 DOI: 10.1002/(Sici)1097-4644(19980501)69:2<143::Aid-Jcb5>3.0.Co;2-S |
0.395 |
|
| 1998 |
Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor Cell. 92: 735-745. PMID 9529250 DOI: 10.1016/S0092-8674(00)81402-6 |
0.488 |
|
| 1998 |
Freeman MR, Paul S, Kaefer M, Ishikawa M, Adam RM, Renshaw AA, Elenius K, Klagsbrun M. Heparin‐binding EGF‐like growth factor in the human prostate: Synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen Journal of Cellular Biochemistry. 68: 328-338. PMID 9518259 DOI: 10.1002/(Sici)1097-4644(19980301)68:3<328::Aid-Jcb4>3.0.Co;2-W |
0.421 |
|
| 1997 |
Raab G, Klagsbrun M. Heparin-Binding Egf-Like Growth Factor Biochimica Et Biophysica Acta. 1333. PMID 9426203 DOI: 10.1016/S0304-419X(97)00024-3 |
0.51 |
|
| 1997 |
Suzuki M, Raab G, Moses MA, Fernandez CA, Klagsbrun M. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site Journal of Biological Chemistry. 272: 31730-31737. PMID 9395517 DOI: 10.1074/Jbc.272.50.31730 |
0.407 |
|
| 1997 |
Soker S, Gollamudi-Payne S, Fidder H, Charmahelli H, Klagsbrun M. Inhibition of Vascular Endothelial Growth Factor (VEGF)-induced Endothelial Cell Proliferation by a Peptide Corresponding to the Exon 7-Encoded Domain of VEGF165 Journal of Biological Chemistry. 272: 31582-31588. PMID 9395496 DOI: 10.1074/Jbc.272.50.31582 |
0.456 |
|
| 1997 |
Elenius K, Corfas G, Paul S, Choi CJ, Rio C, Plowman GD, Klagsbrun M. A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. The Journal of Biological Chemistry. 272: 26761-8. PMID 9334263 DOI: 10.1074/Jbc.272.42.26761 |
0.421 |
|
| 1997 |
Gallo RL, Dorschner RA, Takashima S, Klagsbrun M, Eriksson E, Bernfield M. Endothelial cell surface alkaline phosphatase activity is induced by IL-6 released during wound repair. The Journal of Investigative Dermatology. 109: 597-603. PMID 9326397 DOI: 10.1111/1523-1747.Ep12337529 |
0.363 |
|
| 1997 |
Yayon A, Ma YS, Safran M, Klagsbrun M, Halaban R. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases Oncogene. 14: 2999-3009. PMID 9223663 DOI: 10.1038/Sj.Onc.1201159 |
0.459 |
|
| 1997 |
Elenius K, Paul S, Allison G, Sun J, Klagsbrun M. Activation Of Her4 By Heparin-Binding Egf-Like Growth Factor Stimulates Chemotaxis But Not Proliferation The Embo Journal. 16: 1268-1278. PMID 9135143 DOI: 10.1093/Emboj/16.6.1268 |
0.441 |
|
| 1997 |
McCarthy SA, Chen D, Yang BS, Garcia Ramirez JJ, Cherwinski H, Chen XR, Klagsbrun M, Hauser CA, Ostrowski MC, McMahon M. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Molecular and Cellular Biology. 17: 2401-12. PMID 9111309 DOI: 10.1128/Mcb.17.5.2401 |
0.333 |
|
| 1997 |
Asano K, Nakamura H, Lilly CM, Klagsbrun M, Drazen JM. Interferon gamma induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells. Journal of Clinical Investigation. 99: 1057-1063. PMID 9062364 DOI: 10.1172/Jci119233 |
0.41 |
|
| 1997 |
Freeman MR, Yoo JJ, Raab G, Soker S, Adam RM, Schneck FX, Renshaw AA, Klagsbrun M, Atala A. Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. Journal of Clinical Investigation. 99: 1028-1036. PMID 9062361 DOI: 10.1172/Jci119230 |
0.494 |
|
| 1997 |
Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors. Cytokine & Growth Factor Reviews. 7: 259-70. PMID 8971481 DOI: 10.1016/S1359-6101(96)00027-5 |
0.456 |
|
| 1996 |
Moses MA, Marikovsky M, Harper JW, Vogt P, Eriksson E, Klagsbrun M, Langer R. Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. Journal of Cellular Biochemistry. 60: 379-386. PMID 8867813 DOI: 10.1002/(Sici)1097-4644(19960301)60:3<379::Aid-Jcb9>3.0.Co;2-T |
0.559 |
|
| 1996 |
Moses MA, Marikovsky M, Harper JW, Vogt P, Eriksson E, Klagsbrun M, Langer R. Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. Journal of Cellular Biochemistry. 60: 379-86. PMID 8867813 DOI: 10.1002/(SICI)1097-4644(19960301)60:3<379::AID-JCB9>3.0.CO;2-T |
0.517 |
|
| 1996 |
Takashima S, Klagsbrun M. Inhibition of Endothelial Cell Growth by Macrophage-like U-937 Cell-derived Oncostatin M, Leukemia Inhibitory Factor, and Transforming Growth Factor β1 Journal of Biological Chemistry. 271: 24901-24906. PMID 8798767 DOI: 10.1074/Jbc.271.40.24901 |
0.469 |
|
| 1996 |
Riese DJ, Kim ED, Elenius K, Buckley S, Klagsbrun M, Plowman GD, Stern DF. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. The Journal of Biological Chemistry. 271: 20047-52. PMID 8702723 DOI: 10.1074/Jbc.271.33.20047 |
0.401 |
|
| 1996 |
Soker S, Fidder H, Neufeld G, Klagsbrun M. Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF via Its Exon 7-encoded Domain Journal of Biological Chemistry. 271: 5761-5767. PMID 8621443 DOI: 10.1074/Jbc.271.10.5761 |
0.49 |
|
| 1996 |
Gitay-Goren H, Cohen T, Tessler S, Sokerl S, Gengrinovitch S, Rockwell P, Klagsbrun M, Levi BZ, Neufeld G. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells Journal of Biological Chemistry. 271: 5519-5523. PMID 8621410 DOI: 10.1074/Jbc.271.10.5519 |
0.467 |
|
| 1996 |
Marikovsky M, Vogt P, Eriksson E, Rubin JS, Taylor WG, Sasse J, Klagsbrun M. Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation Journal of Investigative Dermatology. 106: 616-621. PMID 8617994 DOI: 10.1111/1523-1747.Ep12345413 |
0.37 |
|
| 1996 |
Ono M, Klagsbrun M, Kohgo Y. Cell killing effect of heparin-binding EGF-like growth factor Pseudomonas exotoxin on human hepatoma cells International Hepatology Communications. 6: 79-84. DOI: 10.1016/S0928-4346(96)00333-7 |
0.427 |
|
| 1995 |
Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, Mekada E. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. Journal of Cell Biology. 128: 929-938. PMID 7876316 DOI: 10.1083/Jcb.128.5.929 |
0.472 |
|
| 1995 |
Mitamura T, Higashiyama S, Taniguchi N, Klagsbrun M, Mekada E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity Journal of Biological Chemistry. 270: 1015-1019. PMID 7836353 DOI: 10.1074/Jbc.270.3.1015 |
0.446 |
|
| 1995 |
Cook PW, Damm D, Garrick BL, Wood KM, Karkaria CE, Higashiyama S, Klagsbrun M, Abraham JA. Carboxyl-terminal truncation of leucine76 converts heparin-binding EGF-like growth factor from a heparin-enhancible to a heparin-suppressible growth factor. Journal of Cellular Physiology. 163: 407-17. PMID 7706382 DOI: 10.1002/Jcp.1041630221 |
0.488 |
|
| 1995 |
Chen X, Raab G, Deutsch U, Zhang J, Ezzell RM, Klagsbrun M. Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface. Journal of Biological Chemistry. 270: 18285-18294. PMID 7629148 DOI: 10.1074/Jbc.270.31.18285 |
0.427 |
|
| 1995 |
Peoples GE, Blotnick S, Takahashi K, Freeman MR, Klagsbrun M, Eberlein TJ. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proceedings of the National Academy of Sciences of the United States of America. 92: 6547-6551. PMID 7604030 DOI: 10.1073/Pnas.92.14.6547 |
0.484 |
|
| 1995 |
Gately S, Tsanaclis AMC, Takano S, Klagsbrun M, Brem S. Cells transfected with the basic fibroblast growth factor gene fused to a signal sequence are invasive in vitro and in situ in the brain Neurosurgery. 36: 780-788. PMID 7596510 DOI: 10.1227/00006123-199504000-00020 |
0.411 |
|
| 1995 |
Goishi K, Higashiyama S, Klagsbrun M, Nakano N, Umata T, Ishikawa M, Mekada E, Taniguchi N. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Molecular Biology of the Cell. 6: 967-980. PMID 7579712 DOI: 10.1091/Mbc.6.8.967 |
0.44 |
|
| 1995 |
Mangrulkar RS, Ono M, Ishikawa M, Takashima S, Klagsbrun M, Nowak RA. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium. Biology of Reproduction. 53: 636-46. PMID 7578688 DOI: 10.1095/Biolreprod53.3.636 |
0.482 |
|
| 1995 |
Moses MA, Klagsbrun M, Shing Y. The role of growth factors in vascular cell development and differentiation. International Review of Cytology-a Survey of Cell Biology. 161: 1-48. PMID 7558689 DOI: 10.1016/S0074-7696(08)62495-X |
0.476 |
|
| 1995 |
Shishido Y, Sharma KD, Higashiyama S, Klagsbrun M, Mekada E. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor. The Journal of Biological Chemistry. 270: 29578-85. PMID 7494001 DOI: 10.1074/Jbc.270.49.29578 |
0.422 |
|
| 1994 |
Nakano T, Raines EW, Abraham JA, Klagsbrun M, Ross R. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proceedings of the National Academy of Sciences of the United States of America. 91: 1069-73. PMID 8302833 DOI: 10.1073/Pnas.91.3.1069 |
0.425 |
|
| 1994 |
Wang XN, Das SK, Damm D, Klagsbrun M, Abraham JA, Dey SK. Differential regulation of heparin-binding epidermal growth factor-like growth factor in the adult ovariectomized mouse uterus by progesterone and estrogen. Endocrinology. 135: 1264-71. PMID 8070372 DOI: 10.1210/Endo.135.3.8070372 |
0.337 |
|
| 1994 |
Raab G, Higashiyama S, Hetelekidis S, Abraham JA, Damm D, Ono M, Klagsbrun M. Biosynthesis and processing by phorbol ester of the cells surface-associated precursor form of heparin-binding EGF-like growth factor. Biochemical and Biophysical Research Communications. 204: 592-7. PMID 7980519 DOI: 10.1006/Bbrc.1994.2500 |
0.442 |
|
| 1994 |
Gallo RL, Ono M, Povsic T, Page C, Eriksson E, Klagsbrun M, Bernfield M. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proceedings of the National Academy of Sciences of the United States of America. 91: 11035-9. PMID 7972004 DOI: 10.1073/Pnas.91.23.11035 |
0.389 |
|
| 1994 |
Higashiyama S, Abraham JA, Klagsbrun M. Heparin-binding EGF-like growth factor synthesis by smooth muscle cells. Hormone Research. 42: 9-13. PMID 7959639 DOI: 10.1159/000184137 |
0.462 |
|
| 1994 |
Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun M. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proceedings of the National Academy of Sciences of the United States of America. 91: 2890-2894. PMID 7909156 DOI: 10.1073/Pnas.91.8.2890 |
0.492 |
|
| 1994 |
Iwamoto R, Higashiyama S, Mitamura T, Taniguchi N, Klagsbrun M, Mekada E. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. The Embo Journal. 13: 2322-2330. DOI: 10.1002/J.1460-2075.1994.Tb06516.X |
0.365 |
|
| 1993 |
Klagsbrun M, Dluz S. Smooth muscle cell and endothelial cell growth factors Trends in Cardiovascular Medicine. 3: 213-217. PMID 21244911 DOI: 10.1016/1050-1738(93)90042-5 |
0.486 |
|
| 1993 |
Klagsbrun M, Soker S. VEGF/VPF: The angiogenesis factor found? Current Biology. 3: 699-702. PMID 15335866 DOI: 10.1016/0960-9822(93)90073-W |
0.427 |
|
| 1993 |
Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J, Klagsbrun M. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proceedings of the National Academy of Sciences of the United States of America. 90: 3889-93. PMID 8483908 DOI: 10.1073/Pnas.90.9.3889 |
0.431 |
|
| 1993 |
Higashiyama S, Abraham JA, Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. The Journal of Cell Biology. 122: 933-40. PMID 8349739 DOI: 10.1083/Jcb.122.4.933 |
0.414 |
|
| 1993 |
Powell PP, Klagsbrun M. Regulation of basic fibroblast growth factor mRNA expression in rat C6 glioma cells. Experimental Cell Research. 209: 224-230. PMID 8262139 DOI: 10.1006/Excr.1993.1305 |
0.428 |
|
| 1993 |
Abraham JA, Damm D, Bajardi A, Miller J, Klagsbrun M, Ezekowitz RA. Heparin-binding EGF-like growth factor: characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochemical and Biophysical Research Communications. 190: 125-33. PMID 7678488 DOI: 10.1006/Bbrc.1993.1020 |
0.399 |
|
| 1993 |
Brem H, Klagsbrun M. The role of fibroblast growth factors and related oncogenes in tumor growth. Cancer Treatment and Research. 63: 211-231. PMID 1284026 DOI: 10.1007/978-1-4615-3088-6_10 |
0.377 |
|
| 1992 |
Brigstock DR, Sasse J, Klagsbrun M. Subcellular distribution of basic fibroblast growth factor in human hepatoma cells. Growth Factors (Chur, Switzerland). 4: 189-96. PMID 1662972 DOI: 10.3109/08977199109104815 |
0.392 |
|
| 1992 |
Trippel SB, Whelan MC, Klagsbrun M, Doctrow SR. Interaction of basic fibroblast growth factor with bovine growth plate chondrocytes. Journal of Orthopaedic Research. 10: 638-646. PMID 1323648 DOI: 10.1002/Jor.1100100506 |
0.391 |
|
| 1992 |
Powell PP, Klagsbrun M. Expression of mRNA encoding basic fibroblast growth factor and fibroblast growth factor receptor 1 in developing and adult rat brain Neuroprotocols. 1: 263-268. DOI: 10.1016/1058-6741(92)90037-X |
0.318 |
|
| 1991 |
Besner G, Higashiyama S, Klagsbrun M. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regulation. 1: 811-9. PMID 2088527 DOI: 10.1091/Mbc.1.11.811 |
0.499 |
|
| 1991 |
Rogelj S, Stern D, Klagsbrun M. Construction and expression of transforming gene resulting from fusion of basic fibroblast growth factor gene with signal peptide sequence. Methods in Enzymology. 198: 117-124. PMID 1906971 DOI: 10.1016/0076-6879(91)98013-V |
0.323 |
|
| 1991 |
Munaim SI, Klagsbrun M, Toole BP. Hyaluronan-dependent pericellular coats of chick embryo limb mesodermal cells: induction by basic fibroblast growth factor. Developmental Biology. 143: 297-302. PMID 1899405 DOI: 10.1016/0012-1606(91)90080-M |
0.449 |
|
| 1991 |
Powell PP, Klagsbrun M. Three forms of rat basic fibroblast growth factor are made from a single mRNA and localize to the nucleus. Journal of Cellular Physiology. 148: 202-210. PMID 1880150 DOI: 10.1002/Jcp.1041480204 |
0.365 |
|
| 1991 |
Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64: 841-8. PMID 1847668 DOI: 10.1016/0092-8674(91)90512-W |
0.391 |
|
| 1991 |
Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (New York, N.Y.). 251: 936-9. PMID 1840698 DOI: 10.1126/Science.1840698 |
0.484 |
|
| 1991 |
Weich HA, Iberg N, Klagsbrun M, Folkman J. Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells. Journal of Cellular Biochemistry. 47: 158-164. PMID 1757480 DOI: 10.1002/Jcb.240470209 |
0.523 |
|
| 1991 |
Edelman ER, Mathiowitz E, Langer R, Klagsbrun M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials. 12: 619-26. PMID 1742404 DOI: 10.1016/0142-9612(91)90107-L |
0.426 |
|
| 1991 |
Klagsbrun M. Regulators Of Angiogenesis : Stimulators, Inhibitors, And Extracellular Matrix Journal of Cellular Biochemistry. 47: 199-200. PMID 1724241 DOI: 10.1002/Jcb.240470302 |
0.312 |
|
| 1991 |
Besner GE, Klagsbrun M. Macrophages secrete a heparin-binding inhibitor of endothelial cell growth Microvascular Research. 42: 187-197. PMID 1719354 DOI: 10.1016/0026-2862(91)90086-Q |
0.49 |
|
| 1991 |
Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma Cell. 66: 1095-1104. PMID 1717155 DOI: 10.1016/0962-8924(92)90133-8 |
0.382 |
|
| 1991 |
Vlodavsky I, Fuks Z, Ishai-Michaeli R, Bashkin P, Levi E, Korner G, Bar-Shavit R, Klagsbrun M. Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. Journal of Cellular Biochemistry. 45: 167-76. PMID 1711529 DOI: 10.1002/Jcb.240450208 |
0.452 |
|
| 1991 |
Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annual Review of Physiology. 53: 217-39. PMID 1710435 DOI: 10.1146/Annurev.Ph.53.030191.001245 |
0.465 |
|
| 1991 |
Vloavsky I, Bashkin P, Ishai-Michaeli R, Chajek-Shaul T, Bar-Shavit R, Haimovitz-Friedman A, Klagsbrun M, Fuks Z. Sequestration and release of basic fibroblast growth factor. Annals of the New York Academy of Sciences. 638: 207-220. PMID 1664685 DOI: 10.1111/J.1749-6632.1991.Tb49032.X |
0.391 |
|
| 1991 |
Klagsbrun M, Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell. 67: 229-31. PMID 1655276 DOI: 10.1016/0092-8674(91)90173-V |
0.394 |
|
| 1991 |
BAIRD A, KLAGSBRUN M. The Fibroblast Growth Factor Family An Overview Annals of the New York Academy of Sciences. 638: xi-xii. DOI: 10.1111/J.1749-6632.1991.Tb49010.X |
0.381 |
|
| 1990 |
Finklestein SP, Fanning PJ, Caday CG, Powell PP, Foster J, Clifford EM, Klagsbrun M. Increased levels of basic fibroblast growth factor (bFGF) following focal brain injury. Restorative Neurology and Neuroscience. 1: 387-94. PMID 21551582 DOI: 10.3233/Rnn-1990-1603 |
0.345 |
|
| 1990 |
Weich HA, Iberg N, Klagsbrun M, Folkman J. Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells. Growth Factors Journal. 2: 313-320. PMID 2337475 DOI: 10.3109/08977199009167026 |
0.495 |
|
| 1990 |
Caday CG, Klagsbrun M, Fanning PJ, Mirzabegian A, Finklestein SP. Fibroblast growth factor (FGF) levels in the developing rat brain Developmental Brain Research. 52: 241-246. PMID 2331791 DOI: 10.1016/0165-3806(90)90240-Y |
0.39 |
|
| 1990 |
Casscells W, Speir E, Sasse J, Klagsbrun M, Allen P, Lee M, Calvo B, Chiba M, Haggroth L, Folkman J. Isolation, characterization, and localization of heparin-binding growth factors in the heart. Journal of Clinical Investigation. 85: 433-441. PMID 2298919 DOI: 10.1172/Jci114456 |
0.457 |
|
| 1990 |
Yayon A, Klagsbrun M. Autocrine regulation of cell growth and transformation by basic fibroblast growth factor. Cancer and Metastasis Reviews. 9: 191-202. PMID 2292136 DOI: 10.1007/Bf00046360 |
0.42 |
|
| 1990 |
Yayon A, Klagsbrun M. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin. Proceedings of the National Academy of Sciences of the United States of America. 87: 5346-5350. PMID 2164679 DOI: 10.1073/Pnas.87.14.5346 |
0.423 |
|
| 1990 |
Brigstock DR, Klagsbrun M, Sasse J, Farber PA, Iberg N. Species-specific high molecular weight forms of basic fibroblast growth factor. Growth Factors (Chur, Switzerland). 4: 45-52. PMID 2085440 DOI: 10.3109/08977199009011009 |
0.343 |
|
| 1990 |
Klagsbrun M. The affinity of fibroblast growth factors (FGFs) for heparin; FGF-heparan sulfate interactions in cells and extracellular matrix. Current Opinion in Cell Biology. 2: 857-863. PMID 2083085 DOI: 10.1016/0955-0674(90)90084-R |
0.433 |
|
| 1990 |
Klagsbrun M. Method of purifying endothelial cell growth factors using immobilized heparin Progress in Growth Factor Research. 2: 126. DOI: 10.1016/0955-2235(90)90033-G |
0.419 |
|
| 1989 |
Rogelj S, Klagsbrun M, Atzmon R, Kurokawa M, Haimovitz A, Fuks Z, Vlodavsky I. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells. Journal of Cell Biology. 109: 823-831. PMID 2760114 DOI: 10.1083/Jcb.109.2.823 |
0.478 |
|
| 1989 |
Shing Y, Klagsbrun M, Folkman J. A new method for purifying heparin-binding growth factors. Annals of the New York Academy of Sciences. 556: 166-172. PMID 2735656 DOI: 10.1111/J.1749-6632.1989.Tb22500.X |
0.392 |
|
| 1989 |
Klagsbrun M, Edelman ER. Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 9: 269-278. PMID 2655570 DOI: 10.1161/01.Atv.9.3.269 |
0.419 |
|
| 1989 |
Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, Vlodavsky I. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry. 28: 1737-1743. PMID 2541764 DOI: 10.1021/Bi00430A047 |
0.423 |
|
| 1989 |
Prats H, Kaghad M, Prats AC, Klagsbrun M, Lélias JM, Liauzun P, Chalon P, Tauber JP, Amalric F, Smith JA. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proceedings of the National Academy of Sciences of the United States of America. 86: 1836-1840. PMID 2538817 DOI: 10.1073/Pnas.86.6.1836 |
0.338 |
|
| 1989 |
Buckley-Sturrock A, Woodward SC, Senior RM, Griffin GL, Klagsbrun M, Davidson JM. Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors. Journal of Cellular Physiology. 138: 70-8. PMID 2536037 DOI: 10.1002/Jcp.1041380111 |
0.433 |
|
| 1989 |
Klagsbrun M. The fibroblast growth factor family: structural and biological properties. Progress in Growth Factor Research. 1: 207-235. PMID 2491263 DOI: 10.1016/0955-2235(89)90012-4 |
0.4 |
|
| 1989 |
Rogelj S, Weinberg RA, Fanning P, Klagsbrun M. Characterization of tumors produced by signal peptide-basic fibroblast growth factor-transformed cells Journal of Cellular Biochemistry. 39: 13-23. PMID 2469690 DOI: 10.1002/Jcb.240390103 |
0.424 |
|
| 1988 |
Hamerman D, Taylor S, Kirschenbaum I, Klagsbrun M, Raines EW, Ross R, Thomas KA. Growth factors with heparin binding affinity in human synovial fluid. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 186: 384-9. PMID 3423022 DOI: 10.3181/00379727-186-3-Rc2 |
0.424 |
|
| 1988 |
Rogelj S, Weinberg RA, Fanning P, Klagsbrun M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature. 331: 173-5. PMID 3340164 DOI: 10.1038/331173A0 |
0.466 |
|
| 1988 |
Hannan RL, Kourembanas S, Flanders KC, Rogelj SJ, Roberts AB, Faller DV, Klagsbrun M. Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. Growth Factors (Chur, Switzerland). 1: 7-17. PMID 3272801 DOI: 10.3109/08977198809000242 |
0.4 |
|
| 1988 |
Finklestein SP, Apostolides PJ, Caday CG, Prosser J, Philips MF, Klagsbrun M. Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds Brain Research. 460: 253-259. PMID 3224261 DOI: 10.1016/0006-8993(88)90370-8 |
0.336 |
|
| 1988 |
Munaim SI, Klagsbrun M, Toole BP. Developmental changes in fibroblast growth factor in the chicken embryo limb bud. Proceedings of the National Academy of Sciences of the United States of America. 85: 8091-3. PMID 3186711 DOI: 10.1073/Pnas.85.21.8091 |
0.441 |
|
| 1987 |
Biller JA, Montgomery RK, Grand RJ, Klagsbrun M, Rosenthal A. Characterisation of humoral trophic factors involved in intestinal adaptation using a 3T3 cell growth factor assay. Gut. 28: 243-247. PMID 3692313 DOI: 10.1136/Gut.28.Suppl.243 |
0.387 |
|
| 1987 |
Sasse J, Sullivan R, Klagsbrun M. [30] Purification of Cartilage-Derived Growth Factors Methods in Enzymology. 146: 320-325. PMID 3683207 DOI: 10.1016/S0076-6879(87)46033-3 |
0.364 |
|
| 1987 |
Vlodavsky I, Fridman R, Sullivan R, Sasse J, Klagsbrun M. Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted. Journal of Cellular Physiology. 131: 402-8. PMID 3597545 DOI: 10.1002/Jcp.1041310312 |
0.53 |
|
| 1987 |
Nichols WK, Marken JM, Buckley A, Klagsbrun M, Davidson JM. Differential effects of cartilage-derived growth factor stimulation of collagen secretion by bovine aortic and microvascular endothelial cells. Collagen and Related Research. 6: 505-14. PMID 3581755 DOI: 10.1016/S0174-173X(87)80049-3 |
0.506 |
|
| 1987 |
Shing Y, Davidson S, Klagsbrun M. [4] Purification of polypeptide growth factors from milk Methods in Enzymology. 146: 42-48. PMID 3500386 DOI: 10.1016/S0076-6879(87)46007-2 |
0.46 |
|
| 1987 |
Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix Proceedings of the National Academy of Sciences of the United States of America. 84: 2292-2296. PMID 3470794 DOI: 10.1073/Pnas.84.8.2292 |
0.517 |
|
| 1987 |
Shing Y, Klagsbrun M. Purification and characterization of a bovine colostrum-derived growth factor. Molecular Endocrinology. 1: 335-338. PMID 3274892 DOI: 10.1210/Mend-1-5-335 |
0.44 |
|
| 1987 |
Klagsbrun M, Smith S, Sullivan R, Shing Y, Davidson S, Smith JA, Sasse J. Multiple forms of basic fibroblast growth factor: amino-terminal cleavages by tumor cell- and brain cell-derived acid proteinases Proceedings of the National Academy of Sciences of the United States of America. 84: 1839-1843. PMID 3031655 DOI: 10.1073/Pnas.84.7.1839 |
0.379 |
|
| 1987 |
Klagsbrun M, Sullivan R, Smith S, Rybka R, Shing Y. [8] Purification of endothelial cell growth factors by heparin affinity chromatography Methods in Enzymology. 147: 95-105. PMID 2823056 DOI: 10.1016/0076-6879(87)47101-2 |
0.518 |
|
| 1986 |
Hamerman D, Sasse J, Klagsbrun M. A cartilage-derived growth factor enhances hyaluronate synthesis and diminishes sulfated glycosaminoglycan synthesis in chondrocytes Journal of Cellular Physiology. 127: 317-322. PMID 3754558 DOI: 10.1002/Jcp.1041270220 |
0.426 |
|
| 1986 |
Biller JA, Montgomery RK, Grand RJ, Klagsbrun M, Rosenthal A. Use of a 3T3 cell growth factor assay for the delineation and characterization of humoral trophic factors involved in intestinal adaptation in the rat. Gastroenterology. 91: 448-455. PMID 3721128 DOI: 10.1016/0016-5085(86)90581-0 |
0.373 |
|
| 1986 |
Klagsbrun M, Sasse J, Sullivan R, Smith JA. Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor Proceedings of the National Academy of Sciences of the United States of America. 83: 2448-2452. PMID 3458207 DOI: 10.1073/Pnas.83.8.2448 |
0.473 |
|
| 1986 |
Sullivan R, Klagsbrun M. Purification and assay of intact human basic fibroblast growth factor using heparin-sepharose chromatography Journal of Tissue Culture Methods. 10: 125-132. DOI: 10.1007/Bf01404603 |
0.362 |
|
| 1985 |
Dai S, Klagsbrun M, Shing YW. Human milk-derived growth factor prevents duodenal ulcer formation. Pediatric Research. 19: 916-918. PMID 4047760 DOI: 10.1203/00006450-198509000-00009 |
0.429 |
|
| 1985 |
Hamerman D, Klagsbrun M. Osteoarthritis. Emerging evidence for cell interactions in the breakdown and remodeling of cartilage The American Journal of Medicine. 78: 495-499. PMID 3872069 DOI: 10.1016/0002-9343(85)90344-4 |
0.357 |
|
| 1985 |
Klagsbrun M, Shing Y. Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors. Proceedings of the National Academy of Sciences of the United States of America. 82: 805-809. PMID 3856234 DOI: 10.1073/Pnas.82.3.805 |
0.485 |
|
| 1985 |
Davidson JM, Klagsbrun M, Hill KE, Buckley A, Sullivan R, Brewer PS, Woodward SC. Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor. The Journal of Cell Biology. 100: 1219-27. PMID 3838548 DOI: 10.1083/Jcb.100.4.1219 |
0.402 |
|
| 1985 |
Shing Y, Folkman J, Haudenschild C, Lund D, Crum R, Klagsbrun M. Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor. Journal of Cellular Biochemistry. 29: 275-287. PMID 2418039 DOI: 10.1002/Jcb.240290402 |
0.492 |
|
| 1984 |
Shing YW, Klagsbrun M. Human and bovine milk contain different sets of growth factors. Endocrinology. 115: 273-282. PMID 6610546 DOI: 10.1210/Endo-115-1-273 |
0.428 |
|
| 1984 |
D'Amore PA, Klagsbrun M. Endothelial cell mitogens derived from retina and hypothalamus: biochemical and biological similarities. The Journal of Cell Biology. 99: 1545-9. PMID 6480703 DOI: 10.1083/Jcb.99.4.1545 |
0.494 |
|
| 1984 |
Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor Science. 223: 1296-1299. PMID 6199844 DOI: 10.1126/Science.6199844 |
0.526 |
|
| 1983 |
Sullivan RC, Shing YW, D'Amore PA, Klagsbrun M. Use of size-exclusion and ion-exchange high-performance liquid chromatography for the isolation of biologically active growth factors. Journal of Chromatography. 266: 301-11. PMID 6605352 DOI: 10.1016/S0021-9673(01)90904-5 |
0.401 |
|
| 1982 |
Bekoff MC, Klagsbrun M. Characterization of growth factors in human cartilage Journal of Cellular Biochemistry. 20: 237-245. PMID 7169497 DOI: 10.1002/Jcb.240200304 |
0.428 |
|
| 1981 |
Steimer KS, Klagsbrun M. Serum-free growth of normal and transformed fibroblasts in milk: differential requirements for fibronectin. Journal of Cell Biology. 88: 294-300. PMID 7204495 DOI: 10.1083/Jcb.88.2.294 |
0.381 |
|
| 1981 |
Steimer KS, Packard R, Holden D, Klagsbrun M. The serum‐free growth of cultured cells in bovine colostrum and in milk obtained later in the lactation period Journal of Cellular Physiology. 109: 223-234. PMID 7028764 DOI: 10.1002/Jcp.1041090205 |
0.385 |
|
| 1980 |
Klagsbrun M. Bovine colostrum supports the serum-free proliferation of epithelial cells but not of fibroblasts in long-term culture Journal of Cell Biology. 84: 808-814. PMID 7358799 DOI: 10.1083/Jcb.84.3.808 |
0.377 |
|
| 1980 |
Feig LA, Bellvé AR, Erickson NH, Klagsbrun M. Sertoli cells contain a mitogenic polypeptide. Proceedings of the National Academy of Sciences of the United States of America. 77: 4774-8. PMID 6933525 DOI: 10.1073/Pnas.77.8.4774 |
0.381 |
|
| 1980 |
Golbus MS, Djalali M, Klagsbrun M, Kaback MM, Levenson RM, Epstein CJ. Stimulation of amniotic fluid cell growth by cartilage growth factor. American Journal of Medical Genetics. 6: 107-11. PMID 6108715 DOI: 10.1002/Ajmg.1320060203 |
0.424 |
|
| 1979 |
Klagsbrun M, Neumann J, Tapper D. The mitogenic activity of human breast milk. The Journal of Surgical Research. 26: 417-22. PMID 571031 DOI: 10.1016/0022-4804(79)90029-5 |
0.313 |
|
| 1979 |
Klagsbrun M, Neumann J. The serum-free growth of Balb/c 3T3 cells in medium supplemented with bovine colostrum. Journal of Supramolecular Structure. 11: 349-359. PMID 544922 DOI: 10.1002/Jss.400110310 |
0.385 |
|
| 1978 |
Klagsbrun M. Human milk stimulates DNA synthesis and cellular proliferation in cultured fibroblasts. Proceedings of the National Academy of Sciences of the United States of America. 75: 5057-5061. PMID 283415 DOI: 10.1073/Pnas.75.10.5057 |
0.345 |
|
| 1977 |
Klagsbrun M, Langer R, Levenson R, Smith S, Lillehei C. The stimulation of DNA synthesis and cell division in chondrocytes and 3T3 cells by a growth factor isolated from cartilage. Experimental Cell Research. 105: 99-108. PMID 556995 DOI: 10.1016/0014-4827(77)90155-0 |
0.456 |
|
| 1976 |
Haudenschild CC, Zahniser D, Folkman J, Klagsbrun M. Human vascular endothelial cells in culture: Lack of response to serum growth factors Experimental Cell Research. 98: 175-183. PMID 943296 DOI: 10.1016/0014-4827(76)90477-8 |
0.435 |
|
| 1976 |
Scher CD, Haudenschild C, Klagsbrun M. The chick chorioallantoic membrane as a model system for the study of tissue invasion by viral transformed cells. Cell. 8: 373-382. PMID 182381 DOI: 10.1016/0092-8674(76)90149-5 |
0.346 |
|
| 1976 |
Klagsbrun M, Langer R, Lillehei C, Visser HKA. 11: Stimulation of DNA Synthesis in Cultured Pibroblasts and Chondrocytes by a Cartilage-Derived Growth Factor Pediatric Research. 10: 875-875. DOI: 10.1203/00006450-197610000-00019 |
0.351 |
|
| Show low-probability matches. |